European Parliament Panel Approves Revisions to Clinical Trial Regulations

By Roberta Holland2013-06-05T14:21:00

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

Article
Drug Companies Face Stricter Clinical Trial Regulation Worldwide

2014-02-11T00:00:00Z By Joe Mont
Premium
EU AI Act next GDPR? Proof in the pudding as boardrooms prioritize data governance

2024-12-23T10:00:00Z By Ruth Prickett

Breaches of the EU’s GDPR can cost companies substantial sums and huge reputational damage. Now some are warning that the implementation of the EU’s AI Act will be just as far-reaching, and could potentially lead to similar numbers of cases.
Premium
’Future-proofing’ products for safety next level of regulation under EU GPSR

2024-12-20T16:47:00Z By Neil Hodge

Any product that uses AI needs to be safety assessed for its entire lifespan under new rules that went into effect recently across the EU. Experts warned companies using AI to tailor products could be classed as “manufacturers” and face the same duty of care as developed.